Research Article
Extended-Spectrum β-Lactamases among Enterobacteriaceae Isolated from Urinary Tract Infections in Gaza Strip, Palestine
Table 1
Comparison of antibiotics resistance in 30 ESBL and 55 non-ESBL Enterobacteriaceae.
| | Antibiotics | Resistance in ESBL-producing isolates (%) | Resistance in non-ESBLs-producing isolates (%) | value |
| | Cefotaxime | 30 (100%) | 6 (11%) | 0.000 | | Ceftazidime | 15 (50%) | 4 (7.3%) | 0.000 | | Gentamicin | 10 (33.3%) | 3 (5.5%) | 0.001 | | Ampicillin | 30 (100%) | 32 (58.2%) | 0.000 | | Imipenem | 6 (20.0%) | 7 (12.7%) | 0.278 | | Nalidixic acid | 20 (66.7%) | 7 (12.7%) | 0.000 | | Sulfamethoxazole/trimethoprim | 23 (76.7%) | 18 (32.7%) | 0.000 | | Tobramycin | 15 (50.0%) | 5 (9.1%) | 0.000 | | Ciprofloxacin | 20 (66.7%) | 5 (9.1%) | 0.000 | | Kanamycin | 18 (60.0%) | 9 (16.4%) | 0.000 | | Tetracycline | 18 (60.0%) | 2 (3.6%) | 0.000 | | Cefoxitin | 10 (33.3%) | 1 (1.8%) | 0.000 | | Amikacin | 10 (33.3%) | 3 (5.5%) | 0.001 | | Amoxicillin-clavulanic acid | 10 (33.3%) | 3 (5.5%) | 0.001 | | Chloramphenicol | 12 (40.0%) | 7 (12.7%) | 0.012 |
|
|
